These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25860797)

  • 21. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
    Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
    Perry JR; Ang LC; Bilbao JM; Muller PJ
    Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting the improved outcome of patients with central nervous system metastases managed in clinical trials compared with standard hospital practice.
    Tang JI; Back M; Shakespeare T; Lu JJ; Mukherjee R; Wynne C; Liang S
    Australas Radiol; 2005 Oct; 49(5):390-5. PubMed ID: 16174177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system metastases in women after multimodality therapy for high risk breast cancer.
    Carey LA; Ewend MG; Metzger R; Sawyer L; Dees EC; Sartor CI; Moore DT; Graham ML
    Breast Cancer Res Treat; 2004 Dec; 88(3):273-80. PubMed ID: 15609130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
    Sato Y; Deguchi S; Norose T; Oishi T; Mitsuya K; Sugino T; Akiyama Y; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Hayashi N; Yamaguchi K
    Nagoya J Med Sci; 2023 Nov; 85(4):828-835. PubMed ID: 38155632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.
    Field KM; Drummond KJ; Yilmaz M; Tacey M; Compston D; Gibbs P; Rosenthal MA
    J Clin Neurosci; 2013 Jun; 20(6):783-9. PubMed ID: 23639619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases.
    Meis JM; Martz KL; Nelson JS
    Cancer; 1991 May; 67(9):2342-9. PubMed ID: 1849447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gliosarcoma with multiple extracranial metastases: case report and review of the literature.
    Beaumont TL; Kupsky WJ; Barger GR; Sloan AE
    J Neurooncol; 2007 May; 83(1):39-46. PubMed ID: 17171442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
    Gori S; Rimondini S; De Angelis V; Colozza M; Bisagni G; Moretti G; Sidoni A; Basurto C; Aristei C; Anastasi P; Crinò L
    Oncologist; 2007 Jul; 12(7):766-73. PubMed ID: 17673608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliosarcoma: cytopathologic characteristics on fine-needle aspiration (FNA) and intraoperative touch imprint.
    Parwani AV; Berman D; Burger PC; Ali SZ
    Diagn Cytopathol; 2004 Feb; 30(2):77-81. PubMed ID: 14755755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
    Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
    Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
    Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
    Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metastasis and other central nervous system complications of pleuropulmonary blastoma.
    Priest JR; Magnuson J; Williams GM; Abromowitch M; Byrd R; Sprinz P; Finkelstein M; Moertel CL; Hill DA
    Pediatr Blood Cancer; 2007 Sep; 49(3):266-73. PubMed ID: 16807914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
    Guthrie GD; Eljamel S
    J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
    Han SJ; Yang I; Tihan T; Prados MD; Parsa AT
    J Neurooncol; 2010 Feb; 96(3):313-20. PubMed ID: 19618114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
    Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
    Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.